期刊文献+

SLIT2和TRPV1在子宫腺肌病中的表达及意义

The expression and clinical significance of SLIT2 and TRPV1 in adenomyosis
下载PDF
导出
摘要 目的:研究SLIT2和瞬时受体感受器电位香草酸亚型1(TRPV1)在子宫腺肌病中的表达及其与子宫腺肌病的关系,为子宫腺肌病的诊断和治疗提供新的方法。方法:以35例子宫腺肌病患者的在位及同源异位内膜作为实验组样本,20位非子宫腺肌病患者的正常子宫内膜作为对照组样本,免疫组化分析SLIT2和TRPV1的表达。结果:①SLIT2在异位内膜的阳性表达率大于正常及在位内膜(P<0.01);②TRPV1在异位内膜的表达高于正常及在位内膜,组间比较差异有统计学意义(P<0.01);③SLIT2及TPPV1与痛经严重程度呈正相关(r=0.627,P<0.01;r=0.583,P<0.01);④SLIT2与TRPV1的表达呈正相关(r=0.376,P=0.026)。结论:SLIT2和TRPV1在异位子宫内膜表达明显增强,SLIT2和TRPV1表达强度与子宫腺肌病痛经严重程度相关。 Objective: To explore the expression and the localization of transient receptor potential vanilloid type I(TR- PV1) and SLIT2 in women with and without adenomyosis. Methods: Ectopic and homologous eutopic endometria from 35 women suffering adenomyosis and endometria from 20 women without adenomyosis were sampled for immunohisto- chemical analysis of TRPV1 and SLIT2. Results: The positive expression rate of SLIT2 in ectopic endometria was significantly greater than those in normal and eutopic endometria (P〈0.01). Compared with normal and eutopic endometria, the immunoreactivity of TRPV1 was significantly increased in ectopic endometrium (P〈0.01). The immunoreactivities of both TRPV1 and SLIT2 were positively correlated with the severity of dysmenorrheal (r=0.627 P〈0.01; r = 0.583 P %0.01). Expressions of SLIT2 and TRPV1 were positively correlated ( r = 0. 376 P = 0.026). Conclusion: TRPV1 and SLIT2 may be involved in the severity of dysmenorrheal and found to be significant indicators for dysmen- orrheal severity in women with adenomyosis.
作者 郑昕 朱莉
出处 《中国计划生育学杂志》 2015年第5期305-309,共5页 Chinese Journal of Family Planning
关键词 子宫腺肌病 痛经 免疫组化 SLIT2 瞬时受体感受器电位香草酸亚型1 Adenomyosis Dysmenorrhea Immunohistochemistry SLIT2 Transient receptor potentia vanilloid type 1
  • 相关文献

参考文献16

  • 1Wang B. Xiao Y. Ding BB. et al. Induction of tumor angiogen?esis by SLIT /ROBO signaling and inhioition of cancer growth by blocking Robo activity.Cancer Cell.2003.4(1) :19-29.
  • 2Caterina M. Leffler A. Malmberg A. et al. Impaired nocicep- tion and pain sensation in mice lacking the capsaicin receptor[n.Science. 2000.288: 306-313.
  • 3Liu D. HouJ. Hu X et al. Neuronal Chemorepellent SIit2 in?hibits vascular smooth muscle cell migration by suppressing small CTPase racl activation[J]. Cirulation Research. 2006.98: 480-489.
  • 4Eric MS. Lillian BS, Kartik NR, et al. MicroRNA-218 regu?lates vascular patterning by modulation of Slit/Robo signaling[n.Circulation. 2010,107 (11) : 2161-217l.
  • 5Wang KH, Brose K, Arnott D,et al.Biochsmical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching[J]. Cell. 1999,96(6) :771-784.
  • 6Ning v, Sun Q, Dong v . et al. Slit2- N inhibits PDGF-induced migration in rat airway smooth muscle cells: WASP and Arp2/3 involved[J]. Toxicology, 2011,283(1) : 32-40.
  • 7LeggJA, HerbertJM, Clissold P, et al. Slits and Roundabouts in cancer. tumor angiogenesis and endothelial cell migration[J] . Angiogenesis ,11: 13-2l.
  • 8Macias Hv Moran Av Sarnara Yv et al. SLIT/ROBOI signaling suppresses mammary branching morphogenesis by limiting basal cell number[J] .Dev Cell. 2011 , 20:827-840.
  • 9Givannone D, Reyes M.Reyes Rv et al.Slits affect the timely migration of neural crest cells via robo receptor[J]. Dev Dyn , 2012.242:1274-1288.
  • 10Wong GY, Gavva NR. Therapeutic potential of vanilloid re?ceptor TRPVl agonists and antagonists as analgesics: recent advances . and setbacks[J]. Brain Res Rev, 2009,60: 267-277.

二级参考文献22

  • 1Caterina MJ, Schumacher MA, Tominaga M. The capsaicin receptor: a heat-activated ion channel in the pain pathway[J]. Nature, 1997, 389(6653 ) :816-824.
  • 2Ward SM, Bayguinov J, Won KJ, et al. Distribution of the vanilloid receptor ( VR1 ) in the gastrointestinal tract [ J]. Comp Neurol, 2003, 465 ( 1 ) : 121-135.
  • 3Dinh QT, Gmneberg DA, Mingomataj E. Expression of substance P and vanilloid receptor ( VR1 ) in trigeminal sensory neurons projecting to the mouse nasal mucosa [J]. Neuropeptides, 2003,37 (4) :245-250.
  • 4Olah Z, Szabo T, Karai L, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1 [J]. Biol Chem,2001,276(14) :11021-11030.
  • 5Szallasi A, Cortright DN, Blum CA, et al. The vanilloid receptor TRPV1:10 years from channel cloning to antagonist proof-of-concept[J]. Nat Rev Drug Discov, 2007, 6(5) :357-372.
  • 6Dickenson AH, Dray A. Selective antagonism of capsaicin by capsazepine:evidence for a spinal receptor site in capsaicin-induced antinociception [ J]. Pharmacol, 1999,104 ( 4 ) : 1 045 -1 049.
  • 7Perkins MN, Campbell EA. Capsazepine reversal of the antinociceptive action of capsaicin in vivo[ J]. Pharmacol, 1992,107 (2) : 329-333.
  • 8Seabrook GR, Sutton KG, Jarolimek W, et al. Functional properties of the high-affinity TRPV1 ( VR1 ) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxypheny-lacetate ester) iodo-resiniferatoxin[ J]. J Pharmacol Exp Ther,2002,303 (3) : 1052-1060.
  • 9Shimizu I, Iida T, Hofiuchi N, et al. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro [ J]. Pharmacol Exp Ther, 2005,314 ( 3 ) : 1378-1385.
  • 10Toth A, Blumberg PM, Chen Z, et al. Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population [J]. Mol Pharmacol, 2004, 65(2) :282-291.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部